Sign in
4

Changes in Ownership

BioStem Technologies, Inc. Filed Acc 0001193125-26-445456

Chief Commercial Officer acquired 253 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

HASSETT BARRY · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-01 Exercise or conversion : show line 1 in the form +253 5,256 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-01 Exercise or conversion : show line 2 in the form Restricted Stock Units −253 1,266 D
Loading xslF345X06/ownership.xml…